Biocept, Inc. is an oncology laboratory service company, which engages in the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. The company is headquartered in San Diego, California and currently employs 50 full-time employees. The company went IPO on 2014-02-05. The firm has developed a patented methodology to isolate cancer material that is shed from the primary tumor, such as CSF tumor cells (CSF-TCs) and cell-free DNA (cfDNA). As such, it is a commercial provider of testing services designed to enable clinicians to rapidly detect and monitor cancer biomarkers from a cerebrospinal fluid sample. The firm operates a clinical laboratory and manufactures cell enrichment and extraction microfluidic channels, related equipment and certain reagents to perform the Company’s diagnostic assays in a facility located in San Diego, California. The assays the Company offers are classified as laboratory developed tests (LDT) under the CLIA regulations. The Company’s assays, performed on cerebral spinal fluid, have the potential to provide more contemporaneous information on the characteristics of a patient’s disease.
Principales calificaciones de analistas para BIOCQ
Basado en 9 analistas que dan calificaciones de acciones a BIOCQ, actualizado el Jan 01, 2024
Sell
Strong buy
0
Buy
0
Hold
4
Sell
2
Strong sell
3
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for BIOCQ. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: BIOCQ is a Sell candidate.
BIOCQ stock price ended at $0 on Jueves, after rising NaN%
On the latest trading day Jan 15, 2026, the stock price of BIOCQ rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 3.5K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 4.5K shares were traded, equating to a market value of approximately --.
Señales Técnicas de BIOCQ
Resumen de Señales Técnicas
Señales de compra 1
Señales Neutras 6
Señales de venta 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
BIOCQ actualmente presenta 1 señales de compra y 0 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de -- durante este período. En general, los indicadores técnicos apuntan a una perspectiva Buy para el mediano plazo.
Señales alcistas/bajistas para BIOCQ
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para BIOCQ. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a BIOCQ?
¿Cuáles son los niveles de retroceso de Fibonacci para BIOCQ?
¿Cuál es el RSI de Biocept Inc?
¿Cuál es el precio de Biocept Inc para los próximos 12 meses?